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Abstract
 
Two hematopoietic-specific adapters, src homology 2 domain–containing leukocyte phos-
phoprotein of 76 kD (SLP-76) and linker for activation of T cells (LAT), are critical for T cell
development and T cell receptor (TCR) signaling. Several studies have suggested that SLP-76
and LAT function coordinately to promote downstream signaling. In support of this hypothesis,
we find that a fraction of SLP-76 localizes to glycolipid-enriched membrane microdomains
(GEMs) after TCR stimulation. This recruitment of SLP-76 requires amino acids 224–244.
The functional consequences of targeting SLP-76 to GEMs for TCR signaling are demon-
strated using a LAT/SLP-76 chimeric protein. Expression of this construct reconstitutes TCR-
 
inducted phospholipase C
 
g
 
1 phosphorylation, extracellular signal–regulated kinase activation,
and nuclear factor of activated T cells (NFAT) promoter activity in LAT-deficient Jurkat T cells
(J.CaM2). Mutation of the chimeric construct precluding its recruitment to GEMs diminishes
but does not eliminate its ability to support TCR signaling. Expression of a chimera that lacks
SLP-76 amino acids 224–244 restores NFAT promoter activity, suggesting that if localized,
SLP-76 does not require an association with Gads to promote T cell activation. In contrast,
mutation of the protein tyrosine kinase phosphorylation sites of SLP-76 in the context of the
LAT/SLP-76 chimera abolishes reconstitution of TCR function. Collectively, these experi-
ments show that optimal TCR signaling relies on the compartmentalization of SLP-76 and that
one critical function of LAT is to bring SLP-76 and its associated proteins to the membrane.
Key words: adapter proteins • signal transduction • T cell activation • lipid rafts • protein 
tyrosine kinase
 
Introduction
 
One of the earliest detectable biochemical events after
TCR engagement is the tyrosine phosphorylation of sev-
eral proteins by protein tyrosine kinases (PTKs)
 
1
 
 (1–3).
PTK activation is required for the subsequent initiation of
intracellular signaling leading to new gene expression and
other features of T cell activation (4–7). Although much is
known about both the proximal phosphorylation events as
well as the downstream signaling pathways required for T
cell activation, the mechanisms by which these steps are in-
tegrated after TCR ligation remain less clear. Several stud-
ies have shown that the early phosphorylation events are
required for the creation of multimolecular protein com-
plexes that coordinate the various signals important for suc-
cessful T cell activation (for review see references 8–10).
These complexes are nucleated by adapter molecules, pro-
teins that contain modular domains responsible for mediat-
ing interactions with other molecules within the cell. Re-
cently, two such adapter proteins, src homology (SH)2
domain–containing leukocyte phosphoprotein of 76 kD
(SLP-76) and linker for activation of T cells (LAT), have
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Abbreviations used in this paper:
 
 ERK, extracellular signal–regulated ki-
nase; GEMs, glycolipid-enriched membrane microdomains; ITK, induc-
ible T cell kinase; LAT, linker for activation of T cells, NFAT, nuclear
factor of activated T cells; PLC, phospholipase C; PTK, protein tyrosine
kinase; PV, pervanadate; SLP-76, src homology 2 domain–containing
leukocyte phosphoprotein of 76 kD. 
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been shown to be indispensable for T cell development and
activation (11–16).
SLP-76 is a cytosolic protein expressed in T cells, mac-
rophages, NK cells, and platelets (17, 18). It consists of an
NH
 
2
 
-terminal acidic region that includes several tyrosines
that are phosphorylated after TCR engagement (19, 20).
These phosphotyrosines bind to SH2 domains of key sig-
naling molecules, including Vav (21–24), an exchange fac-
tor for the Rac GTPase, and inducible T cell kinase (ITK),
a Tec family PTK (25–27). The central region of SLP-76 is
rich in proline residues, enabling SLP-76 to associate con-
stitutively with Gads (also known as GrpL, Grf40, or
Mona) via the two Gads SH3 domains (28–31). The
COOH-terminal region of SLP-76 contains an SH2 do-
main that binds to another hematopoietic specific adapter
molecule (SLP-76–associated phosphoprotein of 130 kD
[SLAP-130], also known as Fyb) after TCR engagement
and tyrosine phosphorylation of SLAP-130 (32, 33).
LAT is expressed in the same tissues as SLP-76; how-
ever, in contrast to SLP-76, it is a transmembrane protein
(34). Due to posttranslational fatty acid modifications, LAT
is targeted to glycolipid-enriched membrane microdomains
(GEMs, also known as lipid rafts), compartments known to
be critical for concentrating TCR-stimulated signaling
molecules (35, 36). After TCR engagement, GEM-local-
ized LAT is phosphorylated on multiple tyrosine residues,
enabling it to bind SH2 domains of numerous signaling
molecules, including phospholipase C (PLC)
 
g
 
1, the 85-kD
subunit of phosphatidylinositol-3 kinase, and Grb2 (34).
Mutation of these tyrosine residues produces a dominant
negative effect on TCR signaling (34). Interestingly, LAT
also inducibly binds to Gads, allowing for the creation of a
LAT–Gads–SLP-76 trimolecular complex (28–30, 34).
Several lines of evidence have demonstrated that both
SLP-76 and LAT play critical roles in T cell function. Over-
expression of SLP-76 in transformed T cell lines results in
increased efficiency of TCR signaling (37). Mutant variants
of Jurkat T cells, deficient in either SLP-76 (13) or LAT
(14, 15), fail to signal effectively via their TCRs. Although
activation of src and syk family PTKs is retained in Jurkat
cells lacking SLP-76 or LAT, phosphorylation of key sub-
strates (such as PLC
 
g
 
1) is absent, preventing translation of
the most proximal TCR-mediated signaling events into cel-
lular activation (13–15). The most compelling evidence for
the importance of both SLP-76 and LAT in T cell biology
has come from the analysis of mice made deficient in these
proteins by targeted gene disruption (11, 12, 16). Both SLP-
76 and LAT null mice have no peripheral T cells, as devel-
opment is arrested during early thymopoiesis, presumably
due to a failure of the pre-TCR to signal effectively.
Similar signaling defects in SLP-76– and LAT-deficient
Jurkat cells and mice, coupled with the observation that the
two adapters can associate indirectly via Gads, suggested the
possibility that these two proteins function coordinately to
regulate TCR-mediated events. In this report, we describe
experiments performed to test the hypothesis that a major
function of LAT is to recruit SLP-76 to the plasma mem-
brane. First, we demonstrate the inducible translocation of
 
SLP-76 to GEMs. This targeting requires amino acids 224–
244, which were shown previously to encompass the Gads
binding domain of SLP-76. Then, using LAT-deficient Ju-
rkat T cells and various chimeric molecules combining
modules of SLP-76 and LAT, we show that all of the ty-
rosines of LAT are dispensable if SLP-76 is covalently at-
tached to LAT sequences that target the chimeric molecule
to GEMs. We show further that if SLP-76 is tethered to
LAT, the Gads binding site of SLP-76 becomes unneces-
sary for the support of TCR signaling, but SLP-76 ty-
rosines (Y113, 128, and 145) remain essential. Additionally,
although necessary for optimal TCR function, GEM local-
ization of the LAT/SLP-76 chimera is not absolutely essen-
tial. Collectively, our experiments support the conclusion
that in the Jurkat model system, an important role for LAT
is to recruit SLP-76 and its associated molecules to the
membrane, where signaling molecules are concentrated.
 
Materials and Methods
 
Cells and Cell Culture.
 
Mutant variants of Jurkat deficient in
LAT expression (J.CaM2; reference 14) and SLP-76 expression
(J14-v-29; reference 13) were provided by A. Weiss (University
of California, San Francisco, CA). E6-1 Jurkat T cells, J.CaM2,
and J14-v-29 cells were maintained in RPMI 1640 media with
10% FCS, penicillin (1,000 U/ml), streptomycin (1,000 U/ml),
and glutamine (20 mM) in a 5% CO
 
2
 
 humidified atmosphere at
37
 
8
 
C as described previously (38).
 
Antibodies and Reagents.
 
The following antibodies were used:
clonotypic Jurkat anti-TCR mAb C305 (gift from A. Weiss)
(38), anti-LAT polyclonal antisera (gift from L.A. Samelson, Na-
tional Cancer Institute, Bethesda, MD), anti-Gads polyclonal an-
tisera (gift from J. McGlade, Hospital for Sick Children, Toronto,
Ontario), anti-FLAG mAb M2 (International Biotechnologies,
Inc.), antiphospho extracellular signal–regulated kinase (ERK;
New England BioLabs, Inc.), anti-ERK1/2 (Zymed Laborato-
ries), antiphosphotyrosine Ab (4G10), anti-Myc mAb and anti-
PLC
 
g
 
1 mixed mAb (Upstate Biotechnology), and horseradish
peroxidase–conjugated goat anti–mouse IgG (Bio-Rad Laborato-
ries). Luciferin was purchased from Sigma-Aldrich. Horseradish
peroxidase–conjugated cholera toxin B subunit was purchased
from Calbiochem-Novabiochem.
 
cDNA Constructs.
 
The cDNA for pEF/Myc/LAT (Myc-
LAT) was a gift from L.A. Samelson. Flag-SLP-76 (pEF/
Flag/SLP-76, wild type) and the Flag-tagged SLP-76 mutants
pEF/Flag/SLP-76 
 
D
 
224–244 (
 
D
 
224–244), pEF/Flag/SLP-76
Y113/128/145F (Y3F), and pEF/Flag/SLP-7 R448K (R448K)
were cloned as described previously (39). The pEF/LAT/SLP-76
chimeric construct was generated using PCR to generate a cDNA
encoding amino acids 1–35 of the human LAT cDNA (sense
primer, GCAGCGTCGACCCCTGCAGATGGAGGAG; anti-
sense primer, GCGTAGGATCCTGGCAGTCTGTGGCA-
GTG) for ligation into pCRScript easy (Stratagene). The LAT
partial cDNA was then subcloned into pEF/Flag/SLP-76 at the
SalI and BamHI sites, replacing Flag and in frame with the SLP-
76 coding sequence. The LAT/SLP-76 chimeric constructs with
mutations in the SLP-76 coding sequence were generated by re-
placing the wild-type SLP-76 cDNA with the previously de-
scribed SLP-76 mutants at the BamHI and XbaI sites. The LAT/
SLP-76 chimera with point mutations in C26 and C29 was gen-
erated by PCR of pEF/Myc/LAT using the antisense primer 
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CGGATCCTGGCAGTCTGTGGCTGTGCACACTCAGTGC
(underline represents point mutations changing cysteine to serine)
and the original sense primer. The subsequent PCR product was
subcloned in frame with the wild-type SLP-76 sequence as de-
scribed previously.
pEF/HLA-A2, the expression vector containing the HLA-A2
cDNA, was a gift of B. Shraven (University of Heidelberg,
Heidelberg, Germany). pIL-2 nuclear factor of activated T cells
(NFAT)-luciferase (NFAT-luc) was a gift from G. Crabtree (Stan-
ford University, Palo Alto, CA). pCMV/
 
b
 
-galactosidase (
 
b
 
-gal)
was a gift from G. MacGregor (Emory University, Atlanta, GA).
 
Transfections.
 
Cells were washed in PBS and suspended in cy-
tomix (120 mM KCl; 0.15 mM CaCl
 
2
 
; 10 mM K
 
2
 
HPO
 
4
 
/
KH
 
2
 
PO
 
4
 
; 25 mM Hepes, pH
 
 
 
7.6; 2 mM EGTA; 5 mM MgCl
 
2
 
;
pH adjusted with KOH) at a concentration of 2 
 
3
 
 10
 
7
 
 cells per
400 
 
m
 
l of cytomix per cuvette (40). Cells were electroporated at
250 V, 960 
 
m
 
F using a Gene Pulser (Bio-Rad Laboratories). The
cells were placed at 37
 
8
 
C, 5% CO
 
2
 
 for 24 h, followed by func-
tional analysis.
 
Isolation of GEM Fractions Using Equilibrium Density Gradi-
ents.
 
For each GEM preparation, five sets of cells were trans-
fected with 40 
 
m
 
g of plasmid and were then combined. 24 h after
transfection, 5 
 
3
 
 10
 
7
 
 live cells were either left unstimulated or
stimulated via the TCR (1:1,000 C305), followed by lysis at 4
 
8
 
C
for 20 min in 1 ml of MES-buffered saline (25 mM MES, pH
6.5; 150 mM NaCl) containing 1% Triton X-100, 50 mg/ml
aprotinin, 10 mg/ml leupeptin, 50 mg/ml pepstatin A, 1 mM
phenylmethylsulfonyl fluoride, 400 mM sodium vanadate, 10
mM sodium fluoride, and 10 mM sodium pyrophosphate (36,
41). The lysates were then mixed with 1 ml 80% sucrose in
MES-buffered saline and transferred to ultracentrifuge tubes. The
samples were overlaid with 2 ml of 30% sucrose in MES-buffered
saline, followed by 1 ml 5% sucrose in MES-buffered saline. The
Triton-insoluble fractions were separated from the cell lysates by
ultracentrifugation for 18 h at 45,000 rpm in a Beckman SW55Ti
rotor at 4
 
8
 
C (no break). 400-
 
m
 
l fractions were removed sequen-
tially starting from the top of the gradient.
To assess the presence of particular proteins within the cytosol
versus GEMs, 25 
 
m
 
l of each fraction was subjected to SDS-PAGE
(10% for SLP-76, Gads, and LAT; 15% for ganglioside GM1),
followed by transfer to nitrocellulose for immunoblot analysis us-
ing anti–SLP-76, anti-LAT, or anti-Gads polyclonal antisera or
probed for GM1 with horseradish peroxidase–conjugated cholera
toxin B subunit with detection via ECL (Amersham Pharmacia
Biotech).
 
Luciferase Assays.
 
Cells were transfected with 25 
 
m
 
g of
NFAT-luc construct, 5 
 
m
 
g of pCMV/
 
b
 
-gal, and 40 
 
m
 
g of the
expression vectors. The total amount of plasmid DNA was equil-
ibrated to 100 
 
m
 
g with the vector control pEF/HLA-A2. After
24 h, 5 
 
3 
 
10 
 
5
 
 live cells were stimulated in triplicate for 16 h with
media, immobilized anti-TCR mAb C305 (ascites 1:1,000), or
50 ng/ml phorbol ester (PMA) plus 1 
 
m
 
M ionomycin (for maxi-
mal response). Additionally, triplicate samples of 5 
 
3
 
 10 
 
5
 
 un-
stimulated cells were assayed for 
 
b
 
-gal activity using the Galacto-
Light Plus Reporter Gene Assay System (Tropix Inc.). Luciferase
activity was determined as described previously (39). Luciferase
light units were normalized to 
 
b
 
-gal activity present in each
transfectant to standardize for transfection efficiency.
For examination of the expression levels of the transfected
molecules, 10
 
6
 
 transfected cells were lysed in NP-40 lysis buffer
(50 mM Tris buffer, pH
 
 
 
7.4; 1% NP-40; 150 mM NaCl) includ-
ing protease inhibitors (50 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml leupeptin,
50 
 
m
 
g/ml pepstatin A, and 1 mM PMSF). The cell lysates were
 
subjected to SDS-PAGE (10%), followed by transfer to nitrocel-
lulose for immunoblot analysis using either anti–SLP-76 poly-
clonal antisera or anti-Myc mAb.
 
Immunoprecipitations.
 
Transfected Jurkat T cells were left
unstimulated or stimulated with anti-TCR mAb (C305 ascites,
1:1,000) for 5 min and lysed in NP-40 lysis buffer including pro-
tease inhibitors (50 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml leupeptin, 50 
 
m
 
g/
ml pepstatin A, and 1 mM PMSF) and protein phosphatase inhib-
itors (400 
 
m
 
M sodium vanadate, 10 
 
m
 
M sodium fluoride, and 10
 
m
 
M sodium pyrophosphate) (39). In experiments involving the
detection of phosphorylated PLC
 
g
 
1, cells stimulated with per-
vanadate (PV) were used to assess TCR-independent phosphory-
lation as a positive control. For immunoprecipitations, antibodies
(2 
 
m
 
g per immunoprecipitation for anti-PLC
 
g
 
1) were conjugated
to GammaBind Plus Sepharose (Amersham Pharmacia Biotech)
for 2 h at 4
 
8
 
C. Lysates were subjected to precipitation with the
indicated Ab-conjugated Sepharose beads for 2 h at 4
 
8
 
C. The im-
mune complexes were washed three times with NP-40 lysis
buffer with 500 mM NaCl, subjected to SDS-PAGE (10% poly-
acrylamide gels), and transferred to nitrocellulose for immunoblot
analysis using either 4G10 or anti-PLC
 
g
 
1 Ab.
 
Measurement of ERK Activation.
 
Transfected cells were left
unstimulated or were stimulated for 5 min with either C305 or
PMA (50 ng/ml). Then, 10
 
7
 
 cells were lysed in Triton lysis buffer
(1% Triton X-100; 50 mM Hepes, pH
 
 
 
7.6; 150 mM NaCl; 1
mM PMSF; 1 
 
m
 
M aprotinin; 1 mM sodium vanadate; 50 mM
NaFl; 0.5 mM EGTA). Lysates from 2 
 
3 
 
10
 
7
 
 cell equivalents
were subjected to reducing SDS-PAGE (12%) for visualization of
ERK activation by immunoblot analysis using an antiphospho
ERK Ab. For standardization of gel loading, the nitrocellulose
membrane was reprobed for ERK levels by immunoblot analysis.
 
Results
 
SLP-76 Is Recruited to GEMs after TCR Ligation via Pro-
lines within the Central Domain of SLP-76.
 
We and others
have found that SLP-76 associates inducibly with LAT after
TCR engagement (28–30, 34). As LAT is a GEM resident
protein, we reasoned that TCR ligation should therefore
stimulate translocation of SLP-76 to GEMs. Jurkat T cells
were left unstimulated or stimulated via their TCR and
then lysed in a Triton X-100–based buffer. Lysates were
subjected to sucrose density gradient ultracentrifugation to
separate detergent-resistant GEMs from the Triton-soluble
fraction. As described previously (41–43), purity of the
GEM preparation was determined by examining fractions
for the presence of the ganglioside GM1 (Fig. 1 A). As
shown, this marker of GEMs is present only in fractions 2
and 3. Similarly (and confirming previous work of others
[35, 36]), LAT is also found predominantly in GEMs (Fig.
1 B). In contrast, in unstimulated cells, neither SLP-76 nor
Gads is present in the GEM fractions (Fig. 1, C and D). Af-
ter TCR engagement with the clonotypic anti-TCR
C305, a pool of SLP-76 is detected in the GEMs. As ex-
pected, Gads is also inducibly recruited to GEMs, support-
ing the notion that the LAT–Gads–SLP-76 complex is
GEM localized. We have also observed inducible recruit-
ment of SLP-76 to GEMs by confocal microscopy and
colocalization of SLP-76 with FITC-conjugated cholera
toxin after TCR engagement (data not shown). 
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To further test the possibility that it is Gads that bridges
SLP-76 with LAT within GEMs, we transfected Jurkat T
cells with cDNAs encoding either FLAG-tagged wild-type
SLP-76 or similarly tagged SLP-76 variants with mutations
in each of the known SLP-76 protein interaction domains
(Fig. 2 A). Cells were left unstimulated or stimulated via the
TCR and then lysed and fractionated by sucrose density
gradient centrifugation. As shown in Fig. 2 B, wild type and
each of the mutant variants are present in the cytosol in un-
stimulated cells. After TCR engagement, wild-type SLP-76
translocates to GEMs. Additionally, SLP-76 molecules with
alterations in either the tyrosine phosphorylation sites (Y3F)
or the SH2 domain (R448K) also translocate to GEMs after
 
TCR stimulation. In contrast, the SLP-76 mutant that can-
not bind to Gads (
 
D
 
224–244) fails to appear in GEMs after
TCR ligation. (Fig. 2, SLP-76 blot).
 
Targeting SLP-76 to GEMs Replaces the Need for LAT in
Jurkat T Cells.
 
Others have shown that the tyrosines
within the cytoplasmic domain of LAT are critical for
TCR signaling function, presumably because they recruit
effector proteins to a multimolecular signaling complex
(34). We addressed the importance of SLP-76 as one of
these effectors by asking if LAT could function without its
tyrosine residues if SLP-76 was constitutively targeted to
GEMs. This was accomplished by expressing a chimeric
protein including regions of both LAT and SLP-76. As il-
Figure 1. Recruitment of SLP-76 and Gads to GEMs after TCR liga-
tion. Jurkat T cells were either left unstimulated (US) or stimulated with
C305 for 5 min, followed by lysis in MES lysis buffer plus protease and
phosphatase inhibitors. Lysates were subjected to sucrose gradient ultra-
centrifugation for GEM purification. Sequential fractions were removed
starting from the top of the gradient and are indicated as fraction number.
The gradient fractions were separated by SDS-PAGE, followed by detec-
tion of GM1 using horseradish peroxidase–conjugated cholera toxin B
subunit (A) or immunoblot analysis using anti-LAT (B), anti–SLP-76 (C),
or anti-Gads (D).
Figure 2. SLP-76 amino acids 224–244 are required for recruitment of
SLP-76 to GEMs. (A) Schematic of the constructs encoding wild-type
SLP-76 (WT), the SLP-76 mutant with tyrosines 113, 128, and 145 al-
tered to phenylalanine (Y3F), the SLP-76 mutant incapable of binding
Gads (D224–244), and the SLP-76 mutant with a nonfunctional SH2 do-
main (R448K). (B) Jurkat T cells were transfected with the various con-
structs and then left unstimulated or stimulated with C305, followed by
lysis and preparation of GEM fractions as described for Fig. 1. A Triton-
soluble fraction (fraction 11) and a GEM fraction (fraction 3) were sepa-
rated by SDS-PAGE, followed by immunoblot analysis using anti-Flag
(top) or anti–SLP-76 (bottom). Note that in the anti–SLP-76 blot, the
band in the unstimulated D224–244 lane is broader than all other SLP-76
bands. This is due to immunoreactivity of both the endogenous wild-type
SLP-76 and the D224–244 mutant. Also, note that in the stimulated lanes,
only the slower migrating species (wild-type SLP-76) appears. 
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lustrated in Fig. 3 A, the NH
 
2
 
 terminus of the chimera
consists of the extracellular and transmembrane domains
and a limited portion of the cytoplasmic tail of LAT, in-
cluding the two cysteine residues (C26 and C29) previ-
ously shown to be necessary and sufficient for GEM local-
ization of LAT (35, 36). COOH-terminal to the cysteines,
the chimera consists of full length, wild-type SLP-76. Note
that the chimera contains none of the LAT tyrosine resi-
dues shown to be phosphorylated after TCR engagement.
We made use of J.CaM2, a LAT-deficient variant of the
Jurkat T cell line, to study the function of the LAT/SLP-
76 chimera. Cells were transfected with a vector control
(encoding the A2 allele of MHC class I), or cDNA encod-
ing SLP-76, wild-type LAT, or the LAT/SLP-76 chimera.
Transfectants were left unstimulated or stimulated via the
TCR. Cellular lysates were subjected to immunoprecipita-
tion with Ab directed against PLC
 
g
 
1. Immune complexes
 
were then analyzed for the presence of phosphotyrosine
(Fig. 3 B, top) and quantitation of PLC
 
g
 
1 present (Fig. 3
B, bottom). As reported by several groups and shown in
Fig. 3 B, stimulation of the TCR on the LAT-deficient
mutant fails to induce tyrosine phosphorylation of PLC
 
g
 
1.
The TCR-induced PTKs and substrate, however, are in-
tact, as PV stimulates PLC
 
g
 
1 phosphorylation in control
transfected J.CaM2 cells. Confirming published studies (14,
35), TCR-induced PLC
 
g
 
1 phosphorylation is restored by
transfection of cells with wild-type LAT. As expected,
overexpressed SLP-76 does not rescue PLC
 
g
 
1 phosphory-
lation, even though SLP-76 levels in the transfected cells
are substantially higher than endogenous. Surprisingly, ex-
pression of the LAT/SLP-76 chimera also rescues TCR-
stimulated PLC
 
g
 
1 tyrosine phosphorylation. In every ex-
periment, the rescue with the chimera was substantially
higher than when wild-type LAT is overexpressed (data
not shown). The chimeric molecule is also consistently
more efficient at supporting this means of TCR function
than is the combination of transfected wild-type LAT plus
transfected wild-type SLP-76 (data not shown).
Another TCR-stimulated signaling pathway known to
be regulated by both SLP-76 and LAT is activation of
ERK. As shown in Fig. 3 C, stimulation of the TCR on
J.CaM2 fails to activate ERK as assessed by ERK phospho-
rylation, although these cells demonstrate an ERK response
after stimulation with the phorbol ester, PMA. The TCR
signaling defect is reversed by transfection of cDNA en-
coding LAT but not SLP-76. Again, expression of the
LAT/SLP-76 chimera restores TCR-induced ERK acti-
vation more efficiently than does expression of wild-
type  LAT.
NFAT is stimulated downstream of the PLC
 
g
 
1 and
RAS/ERK pathways (8). Therefore, we asked if expression
of the LAT/SLP-76 chimera in LAT-deficient cells could
support TCR-stimulated NFAT activation. Cells were
transfected with the various LAT and SLP-76 constructs
along with a reporter construct including triplicated NFAT
binding sites (derived from the IL-2 promoter) upstream of
the luciferase gene. As shown in Fig. 4, the signaling defect
in J.CaM2 leading to NFAT activation is reversed more ef-
ficiently with the LAT/SLP-76 chimera than with wild-
type LAT. Collectively, these experiments demonstrate
that SLP-76 is a critical molecule recruited by LAT to sup-
port TCR signal transduction in Jurkat T cells.
As SLP-76 is covalently attached to LAT in the chimeric
molecule and hence does not need to be recruited after
TCR engagement, we anticipated that transfection of the
chimera would be more efficient than wild-type LAT at
restoring TCR signaling in J.CaM2. The experiment
shown in Fig. 5 supports this notion, showing that at each
of four concentrations of transfected cDNA, TCR-induced
NFAT activation is more efficient in cells reconstituted
with LAT/SLP-76 when compared with cells receiving
wild-type LAT. Additionally, it appears that the ability of
LAT to increase efficiency of TCR signaling plateaus as the
amount of LAT cDNA is transfected. This is not seen
when the LAT/SLP-76 chimera is expressed (at least at the
Figure 3. Targeting of SLP-76 to GEMs reconstitutes proximal TCR
signaling in LAT-deficient T cells. (A) Schematic of the LAT/SLP-76
chimeric construct used to target SLP-76 to GEMs. The NH2 terminus
contains LAT amino acids 1–35, including the LAT extracellular domain
(EC), transmembrane domain (TM), and amino acids surrounding cys-
teines 26 and 29 (CC). (B) J.CaM2 cells were transfected with HLA-A2
(control), Myc-LAT, Flag–SLP-76, or the LAT/SLP-76 chimera and then
left unstimulated (US), stimulated with C305 (TCR), or stimulated with
PV for 5 min. Lysates were subjected to immunoprecipitation with anti-
PLCg1. Immune complexes were analyzed by SDS-PAGE and immuno-
blot analysis with 4G10 (top) or anti-PLCg1 (bottom). (C) J.CaM2 cells
were transfected with HLA-A2 (control), Myc-LAT, Flag–SLP-76, or the
LAT/SLP-76 chimera and then left unstimulated (US), stimulated with
C305 (TCR), or stimulated with PMA for 5 min. Lysates were subjected
to SDS-PAGE, followed by immunoblot analysis with antiphospho-ERK
(top) and with anti-ERK to ensure equal loading of lanes (bottom). 
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concentrations we have studied). This difference may be
due to limiting amounts of SLP-76 present in J.CaM2 cells
transfected with wild-type LAT. In support of this possibil-
ity, we have found that cotransfection of SLP-76 with LAT
into J.CaM2 is more efficient at rescuing TCR signaling
than transfection of LAT alone (Fig. 5 B).
 
GEM Localization of the LAT/SLP-76 Chimera Is Re-
quired for Optimal Rescue of the J.CaM2 Signaling Defect.
 
Next, we addressed whether GEM localization of SLP-76
is absolutely required to reconstitute TCR function in
J.CaM2. For these experiments, we prepared a mutant
LAT/SLP-76 chimera altering the two LAT cysteines (C26
Figure 4. Targeting of SLP-76 to GEMs
supports reconstitution of NFAT promoter ac-
tivity in LAT-deficient T cells. J.CaM2 cells
were transfected with NFAT-luc and pCMV/
b-gal plus the indicated constructs. 24 h after
transfection, cells were left unstimulated (US),
stimulated with C305, or stimulated with PMA
plus ionomycin for 16 h. Samples were assayed
for luciferase activity (normalized to b-gal; left
panel). PMA plus ionomycin responses were
similar (z100,000 relative light units) for each
sample. This experiment is representative of 10
independent transfections. Expression of the
transfected proteins for this experiment was de-
termined by examining whole cell lysates by
immunoblot analysis with anti–SLP-76 (to de-
tect transfected SLP-76 or the chimera) or anti-
Myc (to detect transfected LAT) antibodies
(right panel).
Figure 5. The LAT/SLP-76 chimera is more efficient at re-
storing TCR signaling in J.CaM2 than wild-type LAT. (A)
J.CaM2 cells were transfected with NFAT-luc and pCMV/b-
gal plus the indicated constructs. 40 mg of plasmid was used
for both the A2 and SLP-76 controls. Varying amounts of
plasmid (from 5 to 40 mg, as shown) encoding LAT or the
LAT/SLP-76 chimera were used. 24 h after transfection, cells
were left unstimulated (US), stimulated with C305, or stimu-
lated with PMA plus ionomycin for 16 h. Samples were as-
sayed for luciferase (normalized to b-gal activity; left panel).
PMA plus ionomycin responses were similar (z120,000 rela-
tive light units) for each sample. This experiment is represen-
tative of four independent transfections. Expression of the
transfected proteins for this experiment was determined by
examining whole cell lysates by immunoblot analysis with
anti–SLP-76 (to detect transfected SLP-76 or the chimera) or
anti-Myc (to detect transfected LAT) antibodies (right panel). (B) J.CaM2 cells were transfected with NFAT-luc and pCMV/b-gal plus the indicated
constructs. 24 h after transfection, cells were left unstimulated (US), stimulated with C305, or stimulated with PMA plus ionomycin for 16 h. Samples
were assayed for luciferase (normalized to b-gal activity; left panel). PMA plus ionomycin responses were similar (z120,000 relative light units) for each
sample. This experiment is representative of three independent transfections. Note the doublet in the SLP-76 blot examining expression of the LAT/
SLP-76 chimera (panel A, right). The slower migrating species represents the chimera, while the faster migrating band is endogenous wild-type SLP-76.1053 Boerth et al.
and C29) responsible for GEM targeting to serine residues
(LAT/SLP-76 CS) (Fig. 6 A). The mutant chimera was
transfected first into J14-v-29, an SLP-76–deficient variant
of Jurkat (13). We chose this cell as a host because it lacks
endogenous SLP-76, making detection of the chimera un-
equivocal. As shown in Fig. 6 B, whereas the LAT/SLP-76
chimera with intact C26 and C29 is found exclusively in
the GEMs (fraction 3), the LAT/SLP-76 CS mutant is
found in the cytosol (fraction 11).
J.CaM2 cells were then transfected with the NFAT re-
porter construct plus control cDNA (A2), wild-type SLP-
76, wild-type LAT, the original LAT/SLP-76 chimera, or
the LAT/SLP-76 CS mutant. Cells were left unstimulated
or stimulated via the TCR and analyzed for NFAT activa-
tion. As shown in Fig. 6 C, expression of LAT/SLP-76 CS
reconstitutes TCR-induced NFAT activation, although al-
ways with less efficiency than the chimera that localizes to
GEMs. These data indicate that when expressed at the
membrane, SLP-76 can support TCR signaling. However,
our results also suggest that for SLP-76 to function opti-
mally, it is necessary for SLP-76 to be targeted to micro-
domains in the membrane.
The SLP-76 Gads Binding Site and SH2 Domain, but Not
Its Tyrosine Phosphorylation Sites, Are Dispensable if SLP-76 Is
Tethered to LAT. The experiments using the LAT/SLP-76
chimeric proteins suggest that a major function of LAT is to
serve as a scaffold for the recruitment of SLP-76 to a TCR-
stimulated signaling complex. The availability of the LAT-
deficient J.CaM2 cells provides an excellent reagent for us
to address the structural features of SLP-76 within the con-
text of the chimera required for the reconstitution of TCR
signaling. To approach this issue, we generated a series of
LAT/SLP-76 chimeras with mutations in each of the three
functional SLP-76 domains. As shown in Fig. 7 A, all of the
constructs contain the LAT extracellular, transmembrane,
and GEM localization sequences. The LAT/SLP-76 Y3F
mutant has three point mutations in the SLP-76 component
preventing its tyrosine phosphorylation. The LAT/SLP-76
D224–244 mutant has a deletion in the Gads binding site,
and the LAT/SLP-76 R448K mutant has a point mutation
in the SH2 domain preventing this protein from binding
SLAP-130/Fyb. Each of the cDNAs for the chimeras was
transfected into J.CaM2 cells for analysis of TCR function.
Fig. 7 B shows the results of representative NFAT assays
for cells expressing each of the chimeric molecules or vari-
ous control constructs. As can be appreciated from this ex-
periment, mutation of either the Gads binding site or the
SH2 domain of SLP-76 decreases the ability of the chimera
to support TCR signaling. However, TCR function is
largely preserved even though expression of these con-
structs compared with LAT or SLP-76 is relatively equal
(Fig. 7 B, right panel). In contrast, mutation of the SLP-76
tyrosine phosphorylation sites completely abrogates the
ability of the chimera to function. This is true also if the
Figure 6. Tethering of SLP-76 to the membrane is suffi-
cient to reconstitute signaling in LAT-deficient T cells. (A)
Schematic of the LAT/SLP-76 chimera with point muta-
tions altering cysteines 26 and 29 to serine. (B) J.14-v-29
cells were transfected with LAT/SLP-76 wild type, LAT/
SLP-76 CS, or FLAG–SLP-76 and then lysed for GEM pu-
rification. The Triton-soluble fractions (fraction 11) and
GEM fractions (fraction 3) were separated by SDS-PAGE,
followed by immunoblot analysis using anti-SLP-76. (C)
J.CaM2 cells were transfected with NFAT-luc, pCMV/b-
gal, and the indicated constructs. 24 h after transfection,
cells were left unstimulated (US), stimulated with C305, or
stimulated with PMA plus ionomycin for 16 h. The samples
were assayed for luciferase activity, which is normalized to
the b-gal activity (left panel). PMA plus ionomycin re-
sponses were similar (z250,000 relative light units) for each
condition. This experiment is representative of four inde-
pendent transfections. Expression of the transfected proteins
in the experiment shown was determined by immunoblot
analysis of whole cell lysates with anti–SLP-76 (to detect
transfected SLP-76 or the chimera) or anti-Myc (to detect
transfected LAT) antibodies (right panel).1054 Rescue of TCR Signaling by a LAT/SLP-76 Chimera
Figure 7. Structure/function analysis of SLP-76 do-
mains required to support TCR-induced NFAT activity in
LAT-deficient cells.  (A) Schematic of the LAT/SLP-76
chimeric constructs used in this experiment. Y3F contains
three point mutations altering tyrosines 113, 128, and 145
to phenylalanine, abrogating tyrosine phosphorylation of
the chimera; D224–244 includes a 20–amino acid deletion
eliminating the Gads binding site; and R448K contains a
point mutation in arginine 448, eliminating function of the
SLP-76 SH2 domain. (B) J.CaM2 cells were transfected
with NFAT-luc, pCMV/b-gal, and the indicated con-
structs. 24 h after transfection, cells were left unstimulated
(US), stimulated with C305, or stimulated with PMA plus
ionomycin for 16 h. The samples were assayed for lu-
ciferase activity, which is normalized to the b-gal activity
(left panel). The PMA plus ionomycin response was similar
(z200,000 relative light units) for each condition. This ex-
periment is representative of five independent transfec-
tions. Expression of the transfected proteins in the experi-
ment shown was determined by immunoblot analysis of
whole cell lysates with anti–SLP-76 (to detect transfected
SLP-76 or the chimera) or anti-Myc (to detect transfected
LAT) antibodies (right panel).
Figure 8. Structure/function analysis of SLP-76 domains required to
support TCR-induced PLCg1 and ERK activity in LAT-deficient cells.
(A) J.CaM2 cells were transfected with the indicated constructs. 24 h
later, cells were left unstimulated (US) or were stimulated with C305
(TCR) or PV for 5 min and then lysed and subjected to immunoprecipi-
tation using anti-PLCg1. The immune complexes were analyzed for
phosphotyrosine contain (4G10, top) and amount of PLCg1 (bottom).
(B) Transfected J.CaM2 cells were stimulated and then analyzed for phos-
pho-ERK (top) and with anti-ERK to ensure equal loading of lanes (bot-
tom) as described for Fig. 3.1055 Boerth et al.
readout of activation is inducible phosphorylation of
PLCg1 or activation of ERK (Fig. 8, A and B).
Thus, if tethered to LAT, the SLP-76 Gads binding site
is no longer critical, presumably because SLP-76 is already
localized to the TCR-stimulated signaling complex. Simi-
larly, mutation of the SH2 domain of SLP-76 does not pre-
vent the chimera from restoring the ability of the TCR to
signal, suggesting that SLP-76 SH2 binder(s) are not critical
for the positive effects of SLP-76 on T cell activation in this
model system. In contrast, however, mutation of the SLP-
76 tyrosine phosphorylation sites completely abolishes the
ability of the chimera to function. We interpret these find-
ings to suggest that for TCR signaling to progress, SLP-76
must coordinate the assembly of a complex including mol-
ecules that associate with the SLP-76 NH2-terminal do-
main. Thus far, several such proteins have been identified,
including Vav, Nck, and ITK, all of which have been
shown previously to play important roles in T cell function.
Discussion
It is becoming increasingly appreciated that effective sig-
nal transduction requires not only the activation of critical
effector molecules but also their concentration into partic-
ular subdomains within the cell. Much recent attention has
focused on GEMs or lipid rafts, membrane subdomains
characterized by detergent insolubility (44, 45). In T cells,
it has been established that the integrity of GEMs and the
localization of specific molecules to these microdomains is
necessary for TCR-initiated signals to be translated into
cellular activation (46). Some of these proteins are GEM
resident (due to their posttranslational modification, e.g.,
LAT), whereas others are recruited into GEMs via induced
associations with other molecules (35, 46–49).
In the experiments described in this report, we focused
on the relationship of LAT and SLP-76 and the impor-
tance of their colocalization into GEMs for TCR signal-
ing. We found that, similar to other critical modulators of
the T cell response, SLP-76 inducibly translocates to
GEMs after TCR ligation. We show additionally that this
translocation requires amino acids within the proline-rich
region of SLP-76, supporting the notion that GEM local-
ization of SLP-76 is indirect. The recruitment of SLP-76
to GEMs likely occurs via an interaction with Gads, an
adapter whose binding to SLP-76 requires the sequence
mutated in the SLP-76 D224–244 construct. To test the
importance of the LAT–SLP-76 interaction, we created a
LAT/SLP-76 chimera that constitutively places SLP-76
within the GEMs and found that expression of this protein
in a LAT-deficient cell restores the ability of the TCR to
signal. In fact, this rescue is more efficient than reconsti-
tuting the mutant cell with wild-type LAT. Although the
chimera possesses no LAT tyrosines, expression of the chi-
mera reconstitutes multiple TCR-inducible biochemical
events leading to transcriptional activation of an NFAT re-
porter construct. As SLP-76 has no intrinsic effector activ-
ity, we speculated that the LAT/SLP-76 chimera must
function by allowing SLP-76 to recruit other molecules to
a larger signaling complex. This appears to be the case, as
the signal transduction rescue is completely abrogated if
the chimeric construct is mutated so the SLP-76 compo-
nent can no longer be phosphorylated and therefore is in-
capable of recruiting other phosphotyrosine binding pro-
teins.
Although we began these experiments with the hypoth-
esis that the LAT/SLP-76 interaction would be critical to
support some aspects of TCR signaling, we speculated that
expression of the chimera on J.CaM2 would provide only a
partial rescue of TCR function. In addition to the residue
responsible for Gads binding, LAT possesses multiple ty-
rosine residues capable of interacting with proteins known
to be important for TCR signal transduction (34). In par-
ticular, LAT binds PLCg1 independent of its interaction
with Gads (and hence SLP-76). Therefore, we predicted
that the LAT/SLP-76 chimera would not support TCR-
induced PLCg1 function in the absence of endogenous
LAT. Our surprising finding that the chimera very effi-
ciently supports TCR-stimulated PLCg1 phosphorylation
(and presumably function, based on the NFAT results) sug-
gests that in addition to being recruited by LAT, PLCg1
may enter a TCR-initiated signaling complex via other av-
enues. In this regard, it is important to note that in addition
to possessing SH2 domains, PLCg1 contains other modules
able to interact with other proteins. In fact, a recent report
demonstrated that the SH2 domains of PLCg1 are not crit-
ical for its recruitment after engagement of the platelet-
derived growth factor receptor (50). An alternative means
by which PLCg1 may be activated after TCR engagement
may involve its association with other proteins by means of
the PLCg1 SH3 domain. Among the potential binders is
SLP-76, as SLP-76 contains a region rich in proline resi-
dues. Experiments are currently underway to determine if
there is a direct recruitment of PLCg1 to the LAT/SLP-76
chimera.
Additional experiments will also be required to deter-
mine which protein(s) must bind to the NH2 terminus of
SLP-76 to maintain the integrity of the TCR signaling
pathway. Several molecules are known to bind to tyrosines
located within this region of SLP-76, and each is being
evaluated as a candidate. These include Vav, an exchange
factor for Rho family GTPases (51); Nck, an adapter pro-
tein (52); and ITK, a Tec family PTK (53). We are particu-
larly interested in the possibility that a SLP-76–ITK inter-
action is required for function of the chimera, as Tec family
PTKs are known to regulate PLCg isoforms (54).
As expected, mutation of the Gads binding site in the
context of the LAT/SLP-76 chimera does not prevent the
rescue of TCR function. This is presumably because once
tethered to LAT, SLP-76 no longer needs to bind Gads.
Interestingly, however, in every experiment where this was
tested, the LAT/SLP-76 D224–244 chimera was less effi-
cient than the chimera containing wild-type SLP-76. Thus,
it appears that optimal signaling may be facilitated by re-
cruitment of Gads or other protein(s) whose association
with SLP-76 requires integrity of the region between
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76 SH2 domain decreases, but does not abolish, the ability
of the chimera to reconstitute TCR function. The only
identified binder to the SLP-76 SH2 is SLAP-130/Fyb, a
protein whose function remains unclear (55–58). Our data
suggest that it is not critical for SLAP-130/Fyb to bind the
targeted SLP-76 chimera for the support of TCR function;
however, optimal activity may rely on this intermolecular
interaction.
It should be noted also that TCR signaling in J.CaM2
cells is still restored even if the LAT/SLP-76 chimera is not
targeted directly to GEMs. In every experiment, this rescue
is substantially decreased compared with studies where
there are similar levels of expression of the LAT/SLP-76
chimera targeted to GEMs. The ability of the nontargeted
chimera to support TCR signaling is comparable to the re-
constitution of activity seen when wild-type LAT is rein-
troduced. These results indicate that merely bringing SLP-
76 to the membrane is sufficient to replace the need for
LAT in the support of TCR signaling; however, this pro-
cess is considerably more efficient if SLP-76 is targeted to
GEMs.
One potential explanation for why SLP-76 can function
to replace LAT even when SLP-76 is not GEM localized
constitutively is that the LAT/SLP-76 CS chimera may be
brought to GEMs through other intermolecular interac-
tions. This is unlikely, however, as the compartmentaliza-
tion of SLP-76 to lipid rafts appears to rely on its Gads
binding domain alone (Fig. 2). A second possibility is that
when expressed at high enough levels at the plasma mem-
brane, SLP-76 may function even when not in GEMs, al-
though GEM localization is critical at lower concentrations
of SLP-76. A third potential explanation is that GEM local-
ization is necessary for LAT phosphorylation (as demon-
strated by Zhang et. al. [15]) and hence SLP-76 recruit-
ment. However, if SLP-76 is tethered to LAT, the
requirement for GEM localization is obviated. Placing the
LAT/SLP-76 chimera within GEMs may still increase
the efficiency of TCR signaling but is not absolutely re-
quired for TCR function.
One limitation of these studies is that by tethering SLP-
76 to LAT, we eliminate the ability of the interaction of
these proteins to be regulated. Thus, while our results indi-
cate that fixing SLP-76 to LAT eliminates the need for
other LAT tyrosines, it is possible that under more physio-
logical conditions, LAT-mediated interactions with other
proteins play additional key roles in TCR signaling. It
should be emphasized also that these experiments were
performed in variants of the Jurkat T cell leukemic line. Al-
though conclusions from studies in Jurkat have often been
borne out by complementary experiments using freshly
isolated human T cells or murine models, there is the po-
tential that results using Jurkat may not recapitulate pre-
cisely the normal biology of T cell activation. We therefore
are planning experiments to examine the effect of expres-
sion of the LAT/SLP-76 chimera in LAT-deficient mice.
Additionally, to test most rigorously the importance of the
LAT–SLP-76 interaction in the regulation of TCR signal-
ing, it will be necessary to develop a system lacking both
endogenous SLP-76 and LAT. To this end, we are estab-
lishing a line of SLP-76/LAT double-knockout mice.
These mice will provide an excellent model system to test
the importance of targeting SLP-76 (both in its wild-type
and mutant forms) to the membrane in general, and GEMs
in particular, for the support of TCR function in vivo.
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